TE VA 7629 Pill - brown round, 9mm
Pill with imprint TE VA 7629 is Brown, Round and has been identified as Imatinib Mesylate 100 mg. It is supplied by Teva Pharmaceuticals USA, Inc.
Imatinib is used in the treatment of Chronic Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Chronic Eosinophilic Leukemia; Dermatofibrosarcoma Protuberans; Gastrointestinal Stromal Tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TE VA 7629
Imatinib Mesylate
- Imprint
- TE VA 7629
- Strength
- 100 mg
- Color
- Brown
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
- 00093-7629
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
FD&C Yellow No. 6,
hypromellose 2910 (6 mPa.s),
ferric oxide yellow,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
sodium stearyl fumarate,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
More about imatinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (47)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
